Quick Answer
Axsome Therapeutics, Inc. reported Shares Outstanding of 50.88 million shares for fiscal year 2025.
Axsome Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 50.88M | +4.6% |
| 2024 | 48.67M | +2.8% |
| 2023 | 47.35M | +8.9% |
| 2022 | 43.50M | +15.0% |
| 2021 | 37.82M | +1.2% |
| 2020 | 37.37M | +1.2% |
| 2019 | 36.93M | +22.8% |
| 2018 | 30.09M | +18.0% |
| 2017 | 25.49M | +33.1% |
| 2016 | 19.15M | +0.0% |
| 2015 | 19.15M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 50.31M | +3.9% | +1.0% |
| June 30, 2025 | 49.82M | +4.2% | +1.2% |
| March 31, 2025 | 49.22M | +3.7% | +1.1% |
| December 31, 2024 | 48.67M | +2.8% | +0.5% |
| September 30, 2024 | 48.44M | +2.4% | +1.3% |
| June 30, 2024 | 47.80M | +2.3% | +0.7% |
| March 31, 2024 | 47.46M | +9.0% | +0.2% |
| December 31, 2023 | 47.35M | +8.9% | +0.1% |
- Axsome Therapeutics, Inc. showed an increase of +4.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Axsome Therapeutics, Inc.’s shares outstanding has grown by 165.7% (from 19.15 million shares to 50.88 million shares).
- The most recent figure is from Axsome Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: